Healthcare -
Biotechnology - NASDAQ - US
$ 29.935
0.69 %
$ 3.72 B
Market Cap
-14.75
P/E
APLS - NET INCOME
Net Income APLS - Apellis Pharmaceuticals, Inc.
-529 M
LAST VALUE
15.84%
2 YEAR CAGR
-32.90%
5 YEAR CAGR
-63.13%
10 YEAR CAGR